Research Topics
| Eric Qiong WuSummaryAffiliation: Analysis Group Country: USA Publications
| Collaborators
|
Detail Information
Publications
Impact of stroke on health-related quality of life in the noninstitutionalized population in the United StatesJipan Xie
Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop K 47, 4770 Buford Hwy, NE, Atlanta, GA 30341 3717, USA
Stroke 37:2567-72. 2006..Stroke is a major cause of long-term disability in the United States. This study examined the national impact of stroke on health-related quality of life (HRQoL) and disparities in HRQoL across different demographic groups...- Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in FranceE Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 23:2035-42. 2007..To estimate the point prevalence of diabetic peripheral neuropathy (DPN) and pain associated with DPN (pDPN) in French adults with diabetes and compare severity of symptoms across demographic subpopulations... 
Outcomes associated with insulin therapy disruption after hospital discharge among patients with type 2 diabetes mellitus who had used insulin before and during hospitalizationEric Q Wu
Analysis Group, Boston, Massachusetts, 02199, USA
Endocr Pract 18:651-9. 2012..To evaluate outcomes associated with insulin therapy disruption after hospital discharge in patients with type 2 diabetes mellitus who had used insulin before and during hospitalization...- Outcomes associated with post-discharge insulin continuity in US patients with type 2 diabetes mellitus initiating insulin in the hospitalEric Q Wu
Analysis Group, Inc, Boston, MA, USA
Hosp Pract (1995) 40:40-8. 2012..We investigated clinical outcomes and hospital readmissions associated with insulin continuation and discontinuation post-discharge in patients with type 2 diabetes mellitus (T2DM) who initiated insulin therapy during hospitalization... - Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature reviewEric Q Wu
Analysis Group, Inc, Boston, MA, USA
CNS Drugs 26:581-600. 2012..Therefore, information regarding the cost effectiveness of different pharmacological treatments is needed to better inform payers in the allocation of limited resources... - Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid populationEric Q Wu
Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor Boston, MA 02199, USA
Manag Care 21:49-58. 2012..Compare treatment persistence and health care costs of major depressive disorder (MDD) Medicaid patients treated with escitalopram versus citalopram... - Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patientsEric Q Wu
Analysis Group Inc, Boston, MA 02199, USA
Curr Med Res Opin 26:61-9. 2010..Objective: To examine the association between adherence with imatinib and direct healthcare costs and resource utilization in a large group of privately insured CML patients... - Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapiesEric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
J Manag Care Pharm 13:561-9. 2007.... - Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patientsEric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
Value Health 10:408-14. 2007..To construct and validate a prediction model of preference-adjusted health status (EQ-5D) for metastatic hormone-refractory prostate cancer (HRPCA) patients using cancer-specific health-related quality of life (HRQoL) measures... - Employees with overactive bladder: work loss burdenEric Q Wu
Analysis Group, Inc, Boston, Massachusetts, USA
J Occup Environ Med 47:439-46. 2005..This study assessed the indirect work loss costs to employers as the result of employees with overactive bladder (OAB)... - Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIsEric Q Wu
Analysis Group, Inc, Boston, MA, USA
J Med Econ 12:124-35. 2009..Compare treatment persistence, healthcare utilisation and costs for patients treated with escitalopram versus other SSRI/SNRIs in a real-world setting... - Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspectiveEric Qiong Wu
Analysis Group, Inc, Boston, MA, USA
Value Health 11:820-9. 2008..To assess the incidence and economic implications of loss of treatment response among patients with Crohn's disease (CD) treated with infliximab maintenance therapy... - Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritisEric Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 24:2229-40. 2008..To describe dosing patterns for tumor necrosis factor (TNF) antagonists in patients with rheumatoid arthritis from health care provider and payer point of interest... - Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?Eric Q Wu
Analysis Group, Inc, Boston, Massachusetts 02199, USA
J Rheumatol 36:1032-40. 2009..We examined the association between serum uric acid (SUA) level and the frequency, risk, and cost of gout flares among the elderly... - Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric populationEric Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 24:2587-95. 2008..To compare escitalopram versus citalopram for the treatment of major depressive disorder (MDD) in geriatric patients... - Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasonsEric Q Wu
Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02199, USA
J Med Econ 13:314-23. 2010..To compare healthcare utilization and costs for major depressive disorder (MDD) patients treated with escitalopram and who were switched to another SSRI for non-medical reasons versus those who did not switch... - Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemiaEric Q Wu
Analysis Group, Inc, Boston, Massachusetts, USA
Curr Med Res Opin 26:2861-9. 2010..To compare healthcare resource utilization, costs, and treatment adherence associated with dasatinib versus nilotinib treatment as second-line therapies in chronic myeloid leukemia (CML) patients... - The economic burden of schizophrenia in the United States in 2002Eric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
J Clin Psychiatry 66:1122-9. 2005..This study quantifies excess annual costs associated with schizophrenia patients in the United States in 2002 from a societal perspective... - Economic burden and co-morbidities of atrial fibrillation in a privately insured populationEric Q Wu
Analysis Group, Inc, Boston, MA 02119, USA
Curr Med Res Opin 21:1693-9. 2005..This study assesses the direct (medical and drugs) and indirect (work loss) annual costs associated with Atrial Fibrillation (AFIB) in a privately insured population... - Interstitial Cystitis: Cost, treatment and co-morbidities in an employed populationEric Q Wu
Analysis Group Inc, Boston, Massachusetts, USA
Pharmacoeconomics 24:55-65. 2006..This study assesses the direct medical cost and indirect cost of work loss for IC patients in the first year after diagnosis, and evaluates IC treatment patterns and prevalence of co-morbidities... - A retrospective claims database analysis to assess patterns of interstitial cystitis diagnosisEric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 22:495-500. 2006..This analysis assesses the potential extent of IC misdiagnosis while considering concomitant conditions in a managed care population and identifies predictors of IC diagnosis... - Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic painEric Q Wu
Analysis Group, Inc, Boston, Massachusetts 02199, USA
J Pain 7:399-407. 2006..From both employer perspective and societal perspective (including patient's out-of-pocket costs), this study demonstrated that duloxetine was more cost-effective than routine treatment in management of DPNP... - Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approachEric Q Wu
Analysis Group, Inc, Boston, MA 02199, USA
Psychol Med 36:1535-40. 2006..This study used multiple administrative claims databases to estimate the annual prevalence of diagnosed schizophrenia in the USA... - Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorderEric Q Wu
Analysis Group Inc, Boston, MA, USA
Ann Pharmacother 45:441-51. 2011..However, little is known about whether these cost-containment strategies can also potentially lower total expenditures for payers in treatment of major depressive disorder (MDD)... - Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims dataEric Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 23:1749-59. 2007..To compare the cost of care for rheumatoid arthritis (RA) patients treated with adalimumab, infliximab, and etanercept... - Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressantsEric Wu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 24:2805-13. 2008.... - The costs of Crohn's disease in the United States and other Western countries: a systematic reviewAndrew Peng Yu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 24:319-28. 2008..To conduct a critical and systematic literature review of the costs of Crohn's disease (CD) in Western industrialized countries... - Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's diseaseAndrew P Yu
Analysis Group, Inc, Boston, Massachusetts 02199, USA
Pharmacoeconomics 27:609-21. 2009..To determine and compare the cost utilities of the tumour necrosis factor (TNF) antagonists adalimumab and infliximab as maintenance therapies for patients in the US with moderately to severely active Crohn's disease... - Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib - a retrospective chart review analysisJames D Griffin
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Curr Med Res Opin 29:623-31. 2013..Nilotinib patients were also less likely than dasatinib patients to subsequently have treatment changes due to ineffectiveness or drug holidays due to intolerance. These findings could be subject to unobserved confounders... - Productivity costs associated with cardiometabolic risk factor clusters in the United StatesPatrick W Sullivan
University of Colorado at Denver and Health Sciences Center, Pharmaceutical Outcomes Research Program, School of Pharmacy, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
Value Health 10:443-50. 2007..The purpose of this study was to examine and quantify the impact of cardiometabolic risk factor clusters independent of heart disease on productivity in a nationally representative sample of US adults... - Disease-related and all-cause health care costs of elderly patients with goutEric Q Wu
Analysis Group, 111 Huntington Ave, 10th Fl, Boston, MA 02199, USA
J Manag Care Pharm 14:164-75. 2008..Older adults with gout are of particular interest because they tend to experience higher rates of tophi, an advanced stage of gout, than do younger patients... - Use of inhaled corticosteroids and healthcare costs in mild persistent asthmaGene Colice
Washington Hospital Center, Washington, DC, USA
J Asthma 44:479-83. 2007..The infrequent inhaled corticosteroid users had significantly more hospitalizations and emergency department visits compared with consistent users... - Healthcare and workloss costs associated with patients with persistent asthma in a privately insured populationG Colice
Washington Hospital Center, Washington, DC, USA
J Occup Environ Med 48:794-802. 2006..0%) relative to moderate (78.1%) and severe (86.4%) patients. CONCLUSIONS: Persistent asthma is expensive. Underutilization of inhaled corticosteroids is higher in patients with mild persistent asthma... 
The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)Ronald C Kessler
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
Biol Psychiatry 58:668-76. 2005..To estimate the prevalence and correlates of clinician-diagnosed DSM-IV nonaffective psychosis (NAP) in a national household survey...- Annual costs associated with diagnosis of uterine leiomyomataKatherine E Hartmann
Center for Women s Health Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7521, USA
Obstet Gynecol 108:930-7. 2006..To describe the annual care, direct health care, and indirect work loss costs for women with a diagnosis of uterine leiomyomata... - Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.SPatrick W Sullivan
University of Colorado Health Sciences Center, School of Pharmacy, Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, Denver, Colorado, USA
Obesity (Silver Spring) 15:511-21. 2007.... - Retrospective economic and outcomes analyses using non-US databases: a reviewLizheng Shi
Department of Health Systems Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana 70112, USA
Pharmacoeconomics 25:563-76. 2007..The quality of non-US retrospective database analyses varied. Future such analyses may be improved if researchers implement the checklist developed by the ISPOR Task Force on Retrospective Database Studies... - Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record dataAndrew P Yu
Analysis Group, Inc, Boston, MA 02199, USA
Curr Med Res Opin 23:2157-69. 2007..Although clinical benefits of weight loss have been established, the economic consequence of weight change among patients with type 2 diabetes is unclear... - Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differencesJipan Xie
Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop K 47, 4770 Buford Hwy NE, Atlanta, GA 30341 3717, USA
Circulation 118:491-7. 2008..Coronary heart disease (CHD) affects 15.8 million Americans. However, data on the national impact of CHD on health-related quality of life, particularly among people of different age, sex, racial, and ethnic groups, are limited...